Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy

被引:90
|
作者
Chappidi, Meera R. [1 ]
Kates, Max [1 ]
Patel, Hiten D. [1 ]
Tosoian, Jeffrey J. [1 ]
Kaye, Deborah R. [1 ]
Sopko, Nikolai A. [1 ]
Lascano, Danny [2 ]
Liu, Jen-Jane [1 ]
McKiernan, James [2 ]
Bivalacqua, Trinity J. [1 ]
机构
[1] Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA
[2] Columbia Univ Coll Phys & Surg, Herbert Irving Canc Ctr, Dept Urol, 630 W 168th St, New York, NY 10032 USA
关键词
Bladder cancer; Frailty; Radical cystectomy; Perioperative outcomes; PERIOPERATIVE COMPLICATIONS; MORTALITY; GENDER; PERFORMANCE; MORBIDITY; RATES; RISK;
D O I
10.1016/j.urolonc.2015.12.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To investigate the modified frailty index (mFI) as a preoperative predictor of postoperative complications following radical cystectomy (RC) in patients with bladder cancer. Materials and methods: Patients undergoing RC were identified from the National Surgical Quality Improvement Program participant use files (2011-2013). The mFI was defined in prior studies with 11 variables based on mapping the Canadian Study of Health and Aging Frailty Index to the National Surgical Quality Improvement Program comorbidities and activities of daily livings. The mFI groups were determined by the number of risk factors per patient (0, 1, 2, and >= 3). Univariable and multivariable regression were performed to determine predictors of Clavien 4 and 5 complications, and a sensitivity analysis was performed to determine the mFI value that would be a significant predictor of Clavien 4 and 5 complications. Results: Of the 2,679 cystectomy patients identified, 843 (31%) of patients had an mFI of 0, 1176 (44%) had an mFI of 1, 555 (21%) had an mFI of 2, and 105 (4%) had an mFI >= 3. Overall, 1585 (59%) of patients experienced a Clavien complication. When stratified at a cutoff of mFI >= 2, the overall complication rate was not different (61.7% vs. 58.3%, P = 0.1), but the mFI2 or greater group had a significantly higher rate of Clavien grade 4 or 5 complications (14.6% vs. 8.3%, P < 0.001) and overall mortality rate (3.5% vs. 1.8%, P = 0.01) in the 30-day postoperative period. The multivariate logistic regression model showed independent predictors of Clavien grade 4 or 5 complications were age > 80 years (odds ratio [OR] = 1.58 [1.11-2.27]), mFI2 (OR = 1.84 [1.28-2.64]), and mFI3 (OR = 2.58 [1.47-4.55]). Conclusions: Among patients undergoing RC, the mFI can identify those patients at greatest risk for severe complications and mortality. Given that bladder cancer is increasing in prevalence particularly among the elderly, preoperative risk stratification is crucial to inform decision-making about surgical candidacy. (c) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:256.e1 / 256.e6
页数:6
相关论文
共 50 条
  • [31] Risk of Ovarian Malignancy in Patients Undergoing Radical Cystectomy for Bladder Cancer
    Abboud, Marc A.
    Topham, Allan K.
    Parker, Daniel C.
    Burks, Heather R.
    Cookson, Michael S.
    Patel, Sanjay G.
    UROLOGY, 2019, 123 : 181 - 185
  • [32] Impact of marital status in patients undergoing radical cystectomy for bladder cancer
    Raj S. Pruthi
    Aaron C. Lentz
    Matthew Sand
    Erik Kouba
    Eric M. Wallen
    World Journal of Urology, 2009, 27 : 573 - 576
  • [33] Impact of anemia on the survival of patients undergoing radical cystectomy for bladder cancer
    Ferran-Carpintero, A.
    Dominguez-Garcia, A.
    Munoz-Rodriguez, J.
    Barquero-Lopez, M.
    Prera-Vilaseca, A.
    Bonfill-Abella, T.
    Gallardo-Diaz, E.
    Hannaoui-Hadi, N.
    Garcia-Rojo, D.
    Prats-Lopez, J.
    ACTAS UROLOGICAS ESPANOLAS, 2020, 44 (07): : 489 - 496
  • [34] Orthotopic bladder substitution for bladder cancer patients undergoing radical cystectomy: A call to action
    Fairey, Adrian S.
    McLarty, Ryan
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2018, 12 (06): : 187 - 187
  • [35] The impact of perivesical lymph node metastasis on clinical outcomes of bladder cancer patients undergoing radical cystectomy
    Meenal Sharma
    Takuro Goto
    Zhiming Yang
    Hiroshi Miyamoto
    BMC Urology, 19
  • [36] The impact of perivesical lymph node metastasis on clinical outcomes of bladder cancer patients undergoing radical cystectomy
    Sharma, Meenal
    Goto, Takuro
    Yang, Zhiming
    Miyamoto, Hiroshi
    BMC UROLOGY, 2019, 19 (01)
  • [37] Survival outcomes in patients with muscle invasive bladder cancer undergoing radical vs. partial cystectomy
    Chung, Rainjade
    Moran, George W.
    Movassaghi, Miyad
    Pohl, Daniel
    Ingram, Justin
    Lenis, Andrew T.
    Mckiernan, James M.
    Anderson, Christopher B.
    Faiena, Izak
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (08) : 356.e11 - 356.e18
  • [38] Frailty impact on postoperative complications and early mortality rates in patients undergoing radical cystectomy for bladder cancer: a systematic review
    Ornaghi, Paola, I
    Afferi, Luca
    Antonelli, Alessandro
    Cerruto, Maria A.
    Mordasini, Livio
    Mattei, Agostino
    Baumeister, Philipp
    Marra, Giancarlo
    Krajewski, Wojciech
    Mari, Andrea
    Soria, Francesco
    Pradere, Benjamin
    Xylinas, Evanguelos
    Tafuri, Alessandro
    Moschini, Marco
    ARAB JOURNAL OF UROLOGY, 2021, 19 (01) : 9 - 23
  • [39] The Impact of the Extent of Lymphadenectomy on Oncologic Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Systematic Review
    Bruins, Harman M.
    Veskimae, Erik
    Hernandez, Virginia
    Imamura, Mari
    Neuberger, Molly M.
    Dahm, Philip
    Stewart, Fiona
    Lam, Thomas B.
    N'Dow, James
    van der Heijden, Antoine G.
    Comperat, Eva
    Cowan, Nigel C.
    De Santis, Maria
    Gakis, Georgios
    Lebret, Thierry
    Ribal, Maria J.
    Sherif, Amir
    Witjes, J. Alfred
    EUROPEAN UROLOGY, 2014, 66 (06) : 1065 - 1077
  • [40] Gender differences in oncologic and functional outcomes in patients with bladder cancer undergoing radical cystectomy with urinary diversion
    Sadighian, Michael
    Porten, Sima
    CURRENT OPINION IN UROLOGY, 2019, 29 (05) : 542 - 547